NOVOZYMES A/S/S (OTCMKTS:NVZMY) Receives $57.00 Average PT from Brokerages
Shares of NOVOZYMES A/S/S (OTCMKTS:NVZMY) have earned a consensus recommendation of “Hold” from the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $57.00.
NVZMY has been the topic of a number of analyst reports. Goldman Sachs Group downgraded shares of NOVOZYMES A/S/S from a “buy” rating to a “sell” rating in a research note on Wednesday, April 1st. ValuEngine upgraded shares of NOVOZYMES A/S/S from a “sell” rating to a “hold” rating in a research report on Saturday, March 14th. Zacks Investment Research raised shares of NOVOZYMES A/S/S from a “hold” rating to a “buy” rating and set a $57.00 price objective on the stock in a research note on Thursday. Finally, Credit Suisse Group cut shares of NOVOZYMES A/S/S from an “outperform” rating to an “underperform” rating in a research note on Tuesday.
OTCMKTS:NVZMY opened at $50.66 on Wednesday. NOVOZYMES A/S/S has a 52 week low of $37.99 and a 52 week high of $55.51. The firm has a 50 day moving average of $47.17 and a 200 day moving average of $48.40. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.29 and a quick ratio of 0.76.
About NOVOZYMES A/S/S
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry.
Recommended Story: What is a good dividend yield?
Receive News & Ratings for NOVOZYMES A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NOVOZYMES A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.